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Matrix metalloprotease-1 (MMP-1) is a member of the large
family of metalloproteases that play an important role in the
remodelling of the extracellular matrix (Matrisian, 1990;
Woessner, 1991). In addition to MMP-2, -8, -13 and -14, MMP-1
is capable of degrading the interstitial collagens I, II and III at a
neutral pH (Nagase et al, 1983). Based on these properties, it has
been suggested that MMP-1 plays a key role in the regulation of
local tumour growth, invasion and metastasis (Salo et al, 1983;
Matrisian, 1990). Representing a potential therapeutic target,
various substances have been investigated, capable of inhibiting
MMP gene expression. In this context, the effects of retinoic acid
(RA) on MMP gene expression have been studied in a wide
variety of different cells and tissues. A rather complex picture has
emerged from these studies: while RA stimulates MMP-13 gene
expression (which shows high homology to human MMP-1) in rat
osteosarcoma cells and rat primary osteoblasts (Conolly et al,
1994; Varghese et al, 1994), inhibition of MMP-1 gene expression
has been observed in synovial cells (Brinckerhoff et al, 1980),
monocytes (Ohta et al, 1987), fibroblasts (Brinckerhoff and Harris,
1981) and epidermal keratinocytes (Bailly et al, 1990); these data
therefore suggest that regulation of MMP gene expression by
retinoic acid occurs in a cell type- and tissue-specific manner. It
should be kept in mind that the interstitial collagenase in rat tissues
(MMP-13) is highly homologous, but not identical to the human
collagenase-3.
It has recently become increasingly clear that epithelial tumour
cells themselves can also act as a source of MMP-1 synthesis
and secretion, thereby directly modulating degradation of the
surrounding extracellular matrix (Chen, 1992). Although RA treat-
ment has been explored in a wide variety of human malignancies
(Bollag and Holdener, 1992), very little is currently known about
the regulation of MMP-1 gene expression by RA in human epithe-
lial cancer cells. As an initial attempt to address this issue, in the
current study we established the human pancreatic carcinoma cell
line Dan-G as an in vitro model to investigate the effects of RA on
MMP-1 gene expression in human pancreatic cancer cells.
MATERIALS AND METHODS
Cell culture
The human pancreatic carcinoma cell line Dan-G was obtained from
the Deutsche Krebsforschungszentrum (Heidelberg, Germany). We
have previously demonstrated by cytokeratin phenotyping, as well
as expression of the duct cell-specific marker gene carbonic anhy-
drase II, that this cell line represents a ductal phenotype (Rosewicz
et al, 1995a, 1995b). Dan-G cells were grown in DMEM supple-
mented with 10% fetal calf serum (FCS). Cells were kept under 95%
air and 5% carbon dioxide at 37°C. 13-cis RA was added from stock
solutions, prepared under subdued light. Control cells received
ethanol as a vehicle control, and the final concentration of ethanol in
the medium did not exceed 0.1%.
Western blots
Cells were cultured in 10-cm Petri dishes in the presence of 10%
FCS until confluency. Medium was then removed and the cells
were thoroughly washed three times to remove serum. Cells were
then switched to serum-free medium with or without the specified
retinoid. After the indicated time intervals, the supernatant was
collected and precipitated with 3% trichloracetic acid (TCA).
Protein samples (10 mg per sample) were then electrophoresed on a
12% sodium dodecyl sulphate (SDS) polyacrylamide gel under
reducing conditions. Proteins were then electroblotted onto nitro-
cellulose membranes. Non-specific binding was blocked by 5%
(w/v) fat-free milk solution. Blots were then incubated with a rabbit
polyclonal antibody directed against human MMP-1 (Quartett,
Berlin, Germany; cat: 5980-0170) at a final dilution of 1:100
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Correspondence to: S Rosewiczovernight. After extensive washing, blots were then reacted with
goat anti-rabbit IgG conjugated to alkaline phosphatase as a second
antibody. Protein bands were subsequently detected using alkaline
phosphatase-dependent nitroblue tetrazolium–bromochloroindoyl
phosphate reduction. The detected signals were then quantitated by
laser densitometry. Identical results were obtained with a mouse
monoclonal anti-human MMP-1 antibody (R&D Sytems,
Wiesbaden, Germany; cat: MAB901).
Northern blots
RNA was isolated by the guanidinium isothyanate procedure
(Chirgwin et al, 1979). RNA was denatured by formaldehyde,
subjected to electrophoresis through a 1% agarose gel in the pres-
ence of formaldehyde and then transferred onto nitrocellulose.
Prehybridization, hybridization and washing procedures were
carried out exactly as previously described (Rosewicz et al, 1994),
using a random primed cDNA probe for human MMP-1. All filters
were stripped and then sequentially hybridized with a cDNA-
encoding human glyceraldehyde 3-phosphate dehydrogenase
(GAPDH), which was used as a loading control. The hybridization
signal was quantitated by laser densitometry, normalized to
GAPDH and then expressed as % of control.
Nuclear run on analysis
Nuclei were isolated by sucrose gradient centrifugation. RNA
products were purified using deoxyribonuclease, proteinase K and
salt precipitation according to the procedure of Nelson and
Groudine (1986). Care was taken that each experimental condition
contained the same amount of nuclei and radioactivity.
Prehybridization, hybridization and washing procedures were
carried out exactly as previously described (Rosewicz et al, 1994).
mRNA stability studies
Dan-G cells were pretreated for 24 h with 13-cis RA or vehicle.
RNA synthesis was then inhibited by the addition of 150 mM of
5,6-dichloro-1b-D-ribofuranosylbenzimidazole (DRB). RNA was
isolated at the indicated time points. MMP-1 mRNA concentra-
tions were then quantitated by slot-blot analysis exactly as
previously described (Rosewicz et al, 1994).
RESULTS
13-cis RA stimulates MMP-1 gene expression in human
pancreatic Dan-G cells
Using a monospecific antibody against human MMP-1 in Western
blotting of Dan-G cell supernatants, we detected a single band of
52 kDa corresponding to the secreted MMP-1 proenzyme (Figure
1A). To evaluate the effects of retinoids, we chose 13-cis RA at a
final concentration of 10 mM because we have previously found that
this concentration is maximally effective in terms of growth inhibi-
tion and induction of cellular differentiation in human pancreatic
carcinoma cells (Rosewicz et al, 1995a). Incubation with 13-cis RA
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Figure 1 Effects of 13-cis retinoic acid on MMP-1 expression in Dan-G
cells. A total of 10 mg TCA-precipitated Dan-G cell supernatant protein were
analysed by Western blotting using a monospecific polyclonal antibody
against human MMP-1, as described in Methods. Shown is a representative
Western blot (A) and the quantitative analysis of three independent
experiments (B) (values are given as mean ± s.e.m.)
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Figure 2 Effects of 13-cis retinoic acid on MMP-1 mRNA concentrations.
Dan-G cells were incubated for the indicated time points with 10 mM 13-cis
RA. Then, 20 mg RNA were analysed by Northern blotting using random-
primed cDNA probes against human MMP-1 and GAPDH, which served as
an internal loading control. Shown is a representative Northern blot (A). The
signals were then quantitated by densitometry and normalized to GAPDH.
Shown are the mean ± s.e.m. of three independent experiments (B)resulted in a time-dependent increase of MMP-1 concentrations
compared to untreated controls, which was detectable as early as 24 h
(357 ± 71% of control) and reached a maximum after 72 h of treat-
ment (1234 ± 381% of control). To further characterize the under-
lying mechanisms responsible for MMP-1 stimulation by 13-cis RA,
we next investigated the effects on MMP-1 mRNA concentrations.
Using a cloned human cDNA for MMP-1 in Northern blotting we
detected a single mRNA species of 2.3 kb corresponding to what has
previously been described for human MMP-1 (Figure 2) (Goldberg
et al, 1986). Treatment of Dan-G cells with 13-cis RA resulted in a
time-dependent increase of MMP-1 mRNA concentrations, which
was detectable as early as 12 h and reached maximal effects at 96 h,
while GAPDH which served as an internal control did not change
under any experimental condition (Figure 2). The effects of 13-cis
RA on MMP-1 gene expression were dose-dependent with half-
maximal effects observed at 100 nM and maximal stimulation occur-
ring at concentrations of 5 mM (Figure 3). When we tested various
naturally occurring retinoid analogues in respect to their potency to
stimulate MMP-1 gene expression in Dan-G cells, we observed the
following gradient based on equimolar concentrations (10 mM): 13-
cis RA (234 ± 42% of control, n = 3) > all-trans RA (183 ± 24% of
control, n = 3) > 9-cis RA (142 ± 2% of control, n = 3).
Effects of 13-cis RA on MMP-1 mRNA stability
To further analyse the molecular mechanisms responsible for the
observed induction of MMP-1 mRNA steady-state concentrations,
we first investigated the effects of 13-cis RA on MMP-1 mRNA
stability. Preincubation of Dan-G cells with 10 mM 13-cis RA for
24 h resulted in a considerable increase of MMP-1 mRNA
stability. The MMP-1 mRNA half-life was calculated to be 31.1 h
(95% confidence interval (CI) 26.2–38.1 h) in control cells in
contrast to 57.8 h (95% CI 48.1–72.6 h) after treatment with 13-cis
RA (Figure 4). Extended treatment beyond 48 h of Dan-G cells
with DRB was not possible due to unacceptable cell toxicity as a
consequence of prolonged inhibition of RNA synthesis.
Effects of 13-cis RA on MMP-1 gene transcription
Although 13-cis RA significantly increased MMP-1 mRNA half-
life, this mechanism cannot fully account for the extent of the
observed increase in MMP-1 mRNA concentrations (e.g. MMP-1
mRNA concentrations were 192 ± 20% of controls after 12 h of
13-cis RA treatment) (Figure 2). We therefore examined whether
13-cis RA might in addition regulate MMP-1 gene transcription.
Using the nuclear run on technique in control nuclei and nuclei
that had been pretreated with 13-cis RA for 24 h we repeatedly
detected an increased hybridization signal for MMP-1 in the RA
pretreated cells (Figure 5). Densitometric analysis revealed a
MMP-1 transcription rate of 185 ± 13% of controls (n = 3) after
13-cis RA pretreatment for 24 h. Retinoic acid did not increase
transcription non-specifically because b-actin gene transcription
was not altered under any experimental condition (Figure 5).
DISCUSSION
In the current study, we investigated the effects of RA on MMP-1
gene expression in human pancreatic carcinoma cells. Using a mono-
specific antibody as well as a human cDNA probe we were able to
demonstrate MMP-1 protein and mRNA expression in the pancreatic
carcinoma cell line Dan-G. These results are in good agreement with
a recent study, demonstrating MMP-1 expression in two highly
metastatic pancreatic carcinoma cell lines (Jimi et al, 1997).
Furthermore, we think that this in vitro system is relevant to the in
vivo biology of pancreatic cancer, because we have subsequently
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Figure 3 Dose-dependent effects of 13-cis retinoic acid on MMP-1 gene
expression. Dan-G cells were incubated for 24 h with the indicated
concentrations of 13-cis RA. RNA was then extracted and analysed by
Northern blotting (A). The signals were then quantitated by densitometry and
normalized to GAPDH (B)
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Figure 4 13-cis retinoic acid increases MMP-1 mRNA half-life. Dan-G cells
were pretreated with 13-cis retinoic acid or vehicle for 24 h. RNA synthesis
was then inhibited by the addition of 150 mM DRB. After the indicated time
points. MMP-1 mRNA was analysed by slot-blot analysis and quantitated by
laser densitometry. Values are given as mean ± s.e.m. of three independent
experimentsfound by immunohistochemistry, that ~50% of all human pancreatic
tumours express MMP-1 protein in the ductal cancer cells, whereas
non-transformed ductal cells are negative, suggesting a central role of
MMP-1 in the remodelling process of the tumour-associated extra-
cellular matrix of pancreatic cancer (von Marschall and Rosewicz,
manuscript in preparation).
RA has been shown to regulate MMP-1 gene expression in a
cell type- and tissue-specific manner (Brinckerhoff et al, 1981,
1980; Ohta et al, 1987; Bailly et al, 1990; Conolly et al, 1994;
Varghese et al, 1994). Depending on the cell system investigated,
induction as well as inhibition of MMP gene expression by RA
have been described, although these regulatory processes are
currently poorly understood in epithelial cancer cells. Using Dan-
G cells as an in vitro model we observed a time- and dose-
dependent induction of MMP-1 protein concentrations by RA. The
increase of MMP-1 protein was paralleled by an increase in MMP-
1 mRNA concentrations, suggesting that RA action occurs mainly
at a pretranslational level. The effects of retinoids are believed to
be mediated by two families of nuclear receptors, designated
retinoic acid receptors (RAR) and retinoid X receptors (RXR),
each consisting of three receptor subtypes, named a, b and g (Leid
et al, 1992; Giguere, 1994). Both RAR and RXR act as ligand-acti-
vated transcription factors, controlling gene transcription initiated
from promotors of retinoid-regulated genes by interacting with
cis-acting elements, the so-called RAREs (retinoic acid responsive
elements) (Leid et al, 1992; Giguere, 1994). We have previously
shown by reverse transcription polymerase chain reaction (RT-
PCR) that the human Dan-G cell line does express all RAR and
RXR subtypes, except for the RXRg (Rosewicz et al, 1995a).
Although most of the biological effects of retinoids are believed to
occur via transcriptional gene regulation, modulation of mRNA
stability by RA has been previously described (Zhou et al, 1994).
To further dissect the molecular mechanisms responsible for
RA-mediated MMP-1 induction, we performed mRNA half-life
studies and nuclear run-on assays in Dan-G cells. As a result of
these experiments, we observed a dual mode of RA action: stimu-
lation of MMP-1 gene transcription and an increase of MMP-1
mRNA stability; both mechanisms contribute to the observed
increase of MMP-1 mRNA and protein concentrations.
This combined regulatory control of MMP-1 gene expression
represents a novel finding compared to what has been previously
described for RA-mediated MMP-1 expression in other cell
systems: in mesenchymal and blood cells, RA results in transcrip-
tional inhibition of MMP-1 without affecting MMP-1 mRNA
stability (Brinckerhoff et al, 1980; Brinckerhoff and Harris, 1981;
Ohta et al, 1987); this inhibition is believed to be due to
protein–protein interactions between the retinoid receptors
(RARs/RXRs) and the AP-1 transcription factor rather than direct
binding of retinoid receptors to regulatory sequences of the MMP-
1 gene (Schule et al, 1991; Pan et al, 1995). In contrast to the regu-
latory effects of RA, Dan-G cells react in a similar fashion to
mesenchymal or blood cells in response to other extracellular
modulators of MMP-1 gene expression. For example, treatment
with the phorbolester TPA results in a time-dependent stimulation
of MMP-1 gene expression in Dan-G cells (data not shown).
In contrast to the regulation of MMP-1 in Dan-G cells, RA stim-
ulates MMP-13 gene transcription in rat osteosarcoma cells
(Conolly et al, 1994), whereas it increases MMP-13 mRNA half-
life in rat primary osteoblasts (Varghese et al, 1994). Taken
together, these data suggest that the composition of the cell type-
specific transcription machinery critically determines the mode of
RA-mediated regulation of MMP gene expression.
In summary, the current study provides the first evidence of
combined transcriptional and post-transcriptional stimulation of
MMP-1 gene expression by RA in a newly established in vitro model
of a MMP-1 expression human pancreatic carcinoma cell line.
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